Table 2. Incidence rate of memory complaint during the COVID-19 in adults at Southern Brazil (n=854).
| Model 1 HR (95%CI)* | p-value | Model 2 HR (95%CI)† | p-value | Model 3 HR (95%CI)† | p-value | Model 4 HR (95%CI)† | p-value | Model 5 HR (95%CI)† | p-value | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Demographic | |||||||||||
| Sex | |||||||||||
| Male (ref) | 1.00 | 0.002 * | 1.00 | 0.003 * | 1.00 | 0.002 * | 1.00 | 0.006 * | 1.00 | 0.002 | |
| Female | 1.58 (1.24–2.00) | 1.50 (1.16–1.93) | 1.49 (1.16–1.93) | 1.49 (1.12–1.97) | 1.49 (1.16–1.94) | ||||||
| Age, years | |||||||||||
| 30 or younger | 1.84 (1.22–2.77) | 0.001† | 1.70 (1.13–2.57) | 0.004† | 1.60 (1.05–2.46) | 0.017† | 1.27 (0.81–1.99) | 0.069† | 1.39 (0.90–2.14) | 0.051† | |
| 31–59 | 1.45 (0.97–2.18) | 1.39 (0.93–2.09) | 1.35 (0.89–2.04) | 1.02 (0.66–1.57) | 1.17 (0.77–1.78) | ||||||
| 60 or older (ref) | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | ||||||
| Educational achievement | |||||||||||
| High school or lower (ref) | 1.00 | 0.278* | |||||||||
| University degree or higher | 0.90 (0.75–1.09) | ||||||||||
| Skin color | |||||||||||
| White (ref) | 1.00 | 0.802* | |||||||||
| Black | 0.87 (0.57–1.32) | ||||||||||
| Mixed | 0.89 (0.53–1.48) | ||||||||||
| Other | 0.54 (0.08–3.87) | ||||||||||
| Conjugal status | |||||||||||
| Living alone (ref) | 1.00 | 0.113 | 1.00 | 0.389* | |||||||
| With partner | 1.16 (0.97–1.38) | 1.09 (0.90–1.33) | |||||||||
| COVID-19 pandemic-related | |||||||||||
| Reduced monthly income | |||||||||||
| No (ref) | 1.00 | 0.002 * | 1.00 | 0.038 * | 1.00 | 0.149* | 1.00 | 0.144* | |||
| Yes | 1.23 (1.03–1.47) | 1.22 (1.01–1.47) | 1.15 (0.95–1.39) | 1.15 (0.95–1.39) | |||||||
| Daily routine | |||||||||||
| At home most of the time (ref) | 1.00 | 0.541* | |||||||||
| Left home only to essentials | 0.88 (0.62–1.24) | ||||||||||
| Left home all days | 0.82 (0.56–1.18) | ||||||||||
| Lack of access to prescribed medicine during the pandemic | |||||||||||
| No | 1.00 | 0.010 * | 1.00 | 0.037 * | 1.00 | 0.037 * | 1.00 | 0.023 * | |||
| Yes | 1.73 (1.20–2.49) | 1.54 (1.06–2.23) | 1.55 (1.07–2.25) | 1.54 (1.06–2.23) | |||||||
| No regular use of medicine | 1.10 (0.89–1.37) | 1.00 (0.79–1.25) | 1.00 (0.80–1.26) | 1.03 (0.82–1.29) | |||||||
| Chronic conditions | |||||||||||
| Hypertension | |||||||||||
| No | 1.00 | 0.864* | |||||||||
| Yes | 1.02 (0.79–1.33) | ||||||||||
| Diabetes | |||||||||||
| No | 1.00 | 0.223* | |||||||||
| Yes | 1.31 (0.85–2.00) | ||||||||||
| Depression | |||||||||||
| No | 1.00 | 0.015 * | 1.00 | 0.250* | |||||||
| Yes | 1.31 (1.06–1.64) | 1.16 (0.90–1.50) | |||||||||
| High cholesterol | |||||||||||
| No | 1.00 | 0.596* | |||||||||
| Yes | 0.92 (0.68–1.24) | ||||||||||
| Other | |||||||||||
| No | 1.00 | 0.777* | |||||||||
| Yes | 0.97 (0.76–1.22) | ||||||||||
| Psychiatric symptoms | |||||||||||
| Worsened anxiety symptoms | |||||||||||
| No | 1.00 | <0.001 * | 1.00 | <0.001 * | 1.00 | <0.001 * | |||||
| Yes | 1.97 (1.62–2.38) | 1.84 (1.51–2.25) | 1.81 (1.49–2.21) | ||||||||
| Worsened depressive symptoms | |||||||||||
| No | 1.00 | <0.001 * | 1.00 | 0.315* | |||||||
| Yes | 1.41 (1.13–1.75) | 1.13 (0.89–1.43) | |||||||||
| Nutritional | |||||||||||
| Body mass index | |||||||||||
| Normal | 1.00 | 0.241† | |||||||||
| Overweight | 0.90 (0.73–1.09) | ||||||||||
| Obese | 0.88 (0.69–1.12) | ||||||||||
| Behavioral | |||||||||||
| Physical activity at baseline | |||||||||||
| Inactive | 1.00 | 0.009 * | 1.00 | 0.018 † | |||||||
| Active | 0.75 (0.60–0.93) | 0.65 (0.57–0.74) | |||||||||
Notes: Bold values indicate p<0.05;
p<0.05 compared to the reference group;
p for linear trend.
Model 1: Crude; Model 2: Age, sex, conjugal; and Model 3: Model 2 plus reduced monthly income and lack of access to prescribed medicine; Model 4: Model 3 plus change in depression and anxiety symptoms and clinically diagnosed depression; Model 5: Model 4 plus physical activity.